BICO Group AB’s Nomination Committee for the 2025 Annual General Meeting
October 9, 2024 7:00 amBICO Group’s major owners have appointed a Nomination Committee and the Annual General Meeting of BICO Group AB will be held on Thursday May 8, 2025.
In accordance with the decision by the Annual General Meeting 2024 when the most recently adopted principles regarding the composition of the nomination committee was made, the Nomination Committee of BICO Group AB shall consist of four members appointed by the largest shareholders. The Chairman of the Board shall not be a member of the Nomination Committee but shall normally be co-opted to the meeting of the Nomination Committee.
The four largest shareholders who wish to participate in the committee are entitled to appoint one member each. In preparation for the 2025 Annual General Meeting the members of the Nomination Committee have been appointed based on the ownership structure as of September 30, 2024, and consists of:
- Erik Gatenholm, nominated by himself
- Jens M. Artelt, nominated by Sartorius Lab Holding GmbH
- Malin Björkmo, nominated by Handelsbanken Fonder (Chairperson of the Nomination Committee)
- Héctor Martínez, nominated by himself
- Rolf Classon, Chairman of the Board of BICO Group AB (co-opted)
Shareholders having appointed members to the Nomination Committee represent approximately 51 percent of the voting rights for all shares of BICO Group AB. The Nomination Committee has also appointed Malin Björkmo as Chairperson of the Nomination Committee.
The Nomination Committee will prepare proposals for the Annual General Meeting 2025 regarding election of chairman/woman and other directors of the board, election of auditor, matters regarding fees, election of chairman/woman of the Annual General Meeting and resolution concerning the Nomination Committee.
Shareholders who wish to submit proposals to the Nomination Committee ahead of the Annual General Meeting 2025 are welcome to contact the Nomination Committee by email: ir@bico.com. Please write “To the Nomination Committee” in the subject line or per mail:
BICO Group AB
att. Nomination Committee
Långfilsgatan 9
412 77 Gothenburg
Sweden
Proposals shall be submitted in writing in due time before the Annual General Meeting, no later than January 31, 2025, to ensure that the proposals can be considered by the Nomination Committee.
For more information, please contact:
Rolf Classon, Chairman of the Board, BICO Group AB
Phone: BICO Investor Relations +46 735 46 57 77
E-mail: ir@bico.com
The information was submitted for publication, through the agency of the contact person set out above, on October 9, 2024 at 7am CEST.
BICO is a lab automation partner and provider of selected workflows to pharma and biotech. With 46,000+ instruments installed in over 65 countries, BICO products, software, and solutions are found in more than 3,500 laboratories, including the world’s top 20 pharmaceutical companies, and have been cited in over 12,000 publications. Operating through three business areas – Lab Automation, Life Science Solutions, and Bioprinting – BICO strives towards the vision to enable and automate the life science lab of the future. BICO is listed on Mid-Cap, Nasdaq Stockholm under BICO. www.bico.com